FILTER VISION PUBLIC COMPANY LIMITED Opportunity Day : Q3.2018 Nov 30, 2018 At The Stock Exchange of Thailand 1
Disclaimer The information contained in this presentation is for information purposes only and does not constitute an offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for share in Filter Vision Public Company Limited (“FVC” and shares in FVC “shares”) in any jurisdiction nor should it or any part of it form the basis of, or be relied upon i n any connection with, any contract or commitment whatsoever. This presentation may include information which is forward-looking in nature. Forward-looking information involve known and unknown risks, uncertainties and other factors which may impact on the actual outcomes, including economic conditions in the markets in which FVC operates and general achievement of FVC business forecasts, which will cause the actual results, performance or achievements of FVC to differ, perhaps materially, from the results, performance or achievements expressed or implied in this presentation. This presentation has been prepared by FVC. The information in this presentation has not been independently verified. No representation, warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information and opinions in this presentation. None of FVC or any of its agents or advisers, or any of their respective affiliates, advisers or representatives, shall have any liability (in negligence or otherwise) for any loss howsoever arising from any use of this presentation or its contents or otherwise arising in connection with this presentation. This presentation is made, furnished and distributed for information purposes only. No part of this presentation shall be relied upon directly or indirectly for any investment decision-making or for any other purposes. This presentation and all other information, materials or documents provided in connection therewith, shall not, either in whole or in part, be reproduced, redistributed or made available to any other person, save in strict compliance with all applicable laws. 2
Contents Business Overview Financial Information Strategy and Outlook Q & A 3
Contents Business Overview Financial Information Strategy and Outlook Q & A 4
Business Overview FVC distribute, design, assembly, install and preventive maintenance of water treatment system and related products Industrial & OEM Commercial & Residential Medical Service B3 B1 B2 B3 (IRV) – Dialysis SOL N , Water and Facility for Hemodialysis ( HD ) B3 ( KTMS) – Hemodialysis Center B3 (MV) – Pneumatic Tube System B3 (HHC) – Healthcare and aesthetics 5
Business Overview B1 : Industrial and OEM Semi Automatic Water Purifier Reverse Osmosis System Automatic Regenerate Softener Filter 6
Business Overview B1 : Industrial and OEM Zero Discharge Wastewater Treatment System Ultra Filtration 7
Business Overview B1 : Industrial and OEM Bio-Well for Dental Bio-Well for Dental 8
Business Overview B2 : Commercial and residential UV System Prefilter R30-BB+7FC Triple+Claris L 9
Business Overview B2 : Commercial and residential RO system + Everpure High flow triple Water system for drinking water and ice machine 10
Business Overview B2 : Commercial and residential Nitro-Coffee Water INT 11
Business Overview B3 : Medical service IRVING CORPORATION LIMITED Pure Water Treatment System for HD Decoration for HD 12
Business Overview B3 : Medical service IRVING CORPORATION LIMITED Chemical Hood Dialysate Solution Dialyzer Cabinet 13
Business Overview B3 : Medical service KT MEDICAL SERVICE COMPANY LIMITED KT Medical Service Hemodialysis Center 14
Business Overview B3 : Medical service MEDICAL VISION COMPANY LIMITED Pneumatic Tube System 15
Business Overview B3 : Medical service HI HEALTHCARE CENTER COMPANY LIMITED Healthcare and aesthetics clinic under trademark “ Wuttisak Clinic” 16
Customer Segments Industrial & OEM (B1) 17
Customer Segments Commercial & Residential (B2) 18
Customer Segments Commercial & Residential (B2) 19
Customer Segments Medical Service ( B3) 20
Content Business Overview Financial Information Strategy and Outlook Q & A 21
Financial Information Revenue 3Q18 Revenue Breakdown Bt. mil 475.61 459.26 500 394.31 B1 364.91 15% 400 360.75 337.09 B3 302.86 300 46% B2 39% 200 100 3Q17 Revenue Breakdown 0 2013 2014 2015 2016 2017 3Q17 3Q18 B1 increase/ (Bt.mil) 3Q2017 3Q2018 % 19% B3 decrease 26% B1 65.18 70.92 5.74 8.81 % B2 185.21 187.07 1.86 1.00 % B2 B3 86.70 217.62 130.92 151.00 % 55% 22 Total 337.09 475.61 138.52 41.09 %
Financial Information Gross Profit Margin YoY -11.45% 31.64% 28.59% 27.21% 27.94% 26.34% 26.05% 14.60% 2013 2014 2015 2016 2017 3Q17 3Q18 Gross Profit Margin Gross profit margin decreased %, due to >> Some of revenue which increase has low margin. >> However, tend of revenue to increase continuously. 23
Financial Information SG&A 3Q18 SG&A Breakdown (Bt.mil) 79.23 97.08 YoY Others 22.53% Professional 13% 5% 23.16 Depreciation 6% 19.82 Office expense 6% Personnel 65% 52.36 27.37 25.67 26.19 27.72 Traveling 5% 40.12 6.64 7.02 6.65 6.53 SG&A increased by 22.53 % : 13.84 14.35 12.71 13.57 21.56 19.29 Mainly from Personnel expenses 6.89 6.43 5.97 6.35 and expenses of the new subsidiary. Q1'17 Q2'17 Q3'17 Q4'17 3Q17 3Q18 24 Selling Admin Management
Financial Information Net Profit & Net Profit Margin (Bt.mil) % 6.00% 5.06% 4.72% 22.00 YoY -6.64% 17.00 4.00% 2.88% 2.88% 2.38% 12.00 21.69 2.00% AMOUNT 7.00 YoY 9.72 9.72 0.00% 5.69 4.99 2.00 -283.85% 1Q17 2Q17 3Q17 4Q17 3Q17 3Q18 (3.00) -2.00% (8.00) -3.76% -4.00% (13.00) -17.87 (18.00) -6.00% Net Profit Net Profit Margin >> Revenue in new business has insufficient to cover the costs. >> Trend of sale and service income will grown as continues. 25
Financial Information Balance Sheet (Bt.mil) 900 Asset Equity Liabilities 800 213.81 221.57 177.77 123.43 700 600 500 877.14 877.97 835.17 787.13 107.94 400 663.70 657.40 663.33 656.40 70.72 300 466.93 407.05 71.96 76.97 358.99 336.33 285.95 275.40 200 208.98 203.44 100 2013 2014 2015 2016 2017 Q1'18 Q2'18 Q3'18 Assets >> Purchased assets amount 132.11 MB ( from assets agreement amount 66.17 MB. ). >> Account receivable in subsidiaries as increase amount 101.57 MB ( new business 70.47 MB .). >> Inventory in new business as increased amount 20.16 MB ( new business 15.95 MB .). >> Cash and cash equivalent decrease amount 136.58 MB ( mainly from acquisition in new business 95.00 MB ). Liabilities >> Account payable and unearned income in new business amounting 51.91 MB. 26 >> Loan from financial institute amount 46.89 MB.
Financial Information ROA QoQ 4.89% >> Investing in - 0.23% 3.46% 3.46% franchise cannot 2.17% 1.67% generate a good return in short term. 1Q17 2Q17 3Q17 4Q17 4Q17 1Q18 2Q18 3Q18 -2.63% -2.86% -3.11% ROE QoQ 6.29% - 0.31% 4.24% 4.24% 2.60% 2.01% 1 Q 17 2 Q 17 3 Q 17 4 Q 17 4 Q 17 1 Q 18 2 Q 18 3 Q 18 -3.30% -3.61% -3.82% 27
Financial Information D/E QoQ 0.02% 0.34 0.32 0.27 0.27 0.19 0.19 0.14 0.14 1Q17 2Q17 3Q17 4Q17 4Q17 1Q18 2Q18 3Q18 D/E ratio increased from previous year, due to >> Loan from financial institute amount 46.89 MB. >> Account payable and unearned income in new business amounting 51.91 MB. 28
Content Business Overview Financial Information Strategy and Outlook Q & A 29
FVC Road Map Food & Beverage Medical Service 2015 Expand market to Medical Service - Capital Increased to 195 MB. Sector . - Purchase land for new office and warehouse (BKK). 2014 Restructure Technical Service Department “Water Treatment” & “Food Equipment”. 2013 IPO on October 29, 2013. 30
FVC Road Map Food & Beverage Medical Service 2018 - Capital Increased to 355.50 MB. - Entered into franchisee of “ Wuttisak Clinic” - Start with new office and warehouse (BKK). - New Local Marketing & Operation in - Launching New Products ; Water INT and Nitro healthcare and esthetics business. Coffee. - ASEAN Medical Device Directive (AMDD) - Re-positioning in Industrial and OEM (B1) supported by the government. - Recognize income from improve wastewater - Exercise the 100 HD machines (approximate). 2017 treatment systems. - Operated 2 new branch of Hemodialysis - Purchase land in Chiang Mai. Center. - Capital increased to 342.79 MB. - On-line Hemodiafiltration. - Special project for discount store. - Capital increased to 40.00 MB. (KTMS) - Water treatment for dental. - Entered MOU with “ Wuttisak Clinic”. 2016 Operated Hemodialysis Center and Pneumatic Tube System. 31
Recommend
More recommend